Your session is about to expire
← Back to Search
MGE + ADT for Prostate Cancer
Study Summary
This trial is testing whether adding muscadine grape extract to androgen deprivation therapy improves symptoms in men with prostate cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can walk, even if I need a device to help me.I am a man, 18 or older, and speak English fluently.I plan to stop hormone therapy or start chemotherapy within a year of joining the study.You are currently taking any other experimental cancer treatments.I have painful cancer spread that needs treatment.I can understand and am willing to sign the consent form.I cannot swallow pills.My prostate cancer was confirmed through a tissue examination.I have not had prostate cancer surgery or radiation in the last 60 days.You have had allergic reactions in the past to similar substances as MGE.I do not have any severe illnesses or social situations that would stop me from following the study's requirements.My PSA levels have increased by more than 0.5 ng/mL while on prostate cancer treatment.I have severe digestion issues causing uncontrolled symptoms despite daily treatment.I agree to use effective birth control or remain abstinent during the study.My recent tests show my organs and bone marrow are functioning well.I am undergoing or have had treatment to lower my testosterone levels for prostate cancer.
- Group 1: MGE group
- Group 2: Placebo group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Can patients be assured that Medical Grade Ethanol is harmless?
"The safety of MGE was rated a 2, due to the lack of efficacy data but presence of previous research that suggested its security."
Is there an ongoing enrollment process for this clinical research?
"This clinical trial, according to information found on clinicialtrials.gov, is currently in search of volunteers; the first posting occurred on January 29th 2019 and was most recently modified on November 2nd 2022."
What is the scope of participation in this research initiative?
"Affirmative. Clinicaltrials.gov notes that this medical trial, initially posted on January 29th 2019, is still searching for patients to enroll. A total of 160 individuals are required at two separate sites."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger